Streetbeat News

Regulatory

VSH

Vishay Intertechnology, Inc.'s (NYSE:VSH) Specialty Thin Film division announced its EFI Warwick factory in Rhode Island has been certified to the IATF 16949:2016 quality standard for its IGBR family of back contact wirebondable gate resistors. This certification, based on ISO 9001:2015 with additional automotive requirements, signifies enhanced quality management for the automotive industry. The EFI Warwick factory's quality management system is now certified to ISO 9001:2015 for all products and IATF 16949:2016 for IGBR resistors, alongside environmental certifications ISO 14001:2015 and ISO 45001:2018.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 4:05 pm

SABS

SAB Biotherapeutics, Inc. (SABS) announced a clinical partnership with the Naval Medical Research Center (NMRC) to advance SAB-176, a potential influenza treatment. The partnership, supported by the Henry Jackson Foundation, will conduct a pharmacokinetic, safety, and tolerability study of SAB-176 in healthy volunteers. SAB-176, developed using SAB's DiversitAb platform, targets influenza A and B and has received Breakthrough Therapy and Fast Track Designations from the FDA. This study marks the first intramuscular administration trial of a DiversitAb platform product.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 2:18 pm

MJ

MSOS

A new poll by the American Bankers Association (ABA) reveals that 63% of Americans support allowing marijuana businesses access to banking services. This comes as Congress sees a renewed push for the Secure and Fair Enforcement (SAFER) Banking Act, aimed at protecting banks serving state-licensed cannabis businesses from federal penalties. Senate Majority Leader Chuck Schumer and Senate Banking Committee Chairman Sherrod Brown have expressed high priority for passing the SAFER Banking Act, with bipartisan and bicameral talks being described as productive. The bill, which has faced delays due to disagreements over non-cannabis banking regulations, is gaining momentum with efforts to bring it to the Senate floor this year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 2:18 pm

AMD

BA

BTCUSD

INTC

Bitcoin's value increased, while AMD and Intel experienced a decline due to new restrictions in China. Boeing's CEO announced plans to step down.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 2:18 pm

FCX

GOLD

NEM

The Biden administration announced a $475 million funding allocation for clean energy projects in the mining sector, targeting companies like Freeport-McMoRan (FCX), Barrick Gold (GOLD), and Newmont (NEM). This initiative aims to support communities affected by the energy transition, with each company pursuing unique projects and strategies. Freeport-McMoRan is focusing on a geothermal and battery storage project in Arizona, Barrick Gold is expanding into copper mining in Africa and the Middle East, and Newmont is streamlining operations post-Newcrest acquisition.

Portfolio Pulse from Stjepan Kalinic

March 25, 2024 | 2:18 pm

FXI

SPY

The Biden administration plans to publicly accuse Chinese hackers, linked to China's Ministry of State Security, of conducting espionage against US companies. This includes criminal charges, sanctions, and rewards for information. The hackers reportedly used a Wuhan-based tech company as a front. The UK is also set to make similar accusations. This announcement comes amid tense US-China cyber relations, following FBI warnings of potential disruptive cyberattacks by another Chinese group.

Portfolio Pulse from Happy Mohamed

March 25, 2024 | 2:18 pm

IVVD

The FDA granted emergency use authorization to Invivyd Inc's Pemgarda for COVID-19 prevention in individuals with immune compromise. Invivyd announced financial details, including a cash runway into Q4 2024, and shared interim data from the CANOPY Phase 3 trial of VYD222 (Pemgarda), showing promising results against COVID-19. However, IVVD shares dropped 13.20% to $3.79.

Portfolio Pulse from Vandana Singh

March 25, 2024 | 1:44 pm

LXRX

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced four presentations on sotagliflozin at the American College of Cardiology session, highlighting its efficacy in reducing stroke and heart attack risk among patients with type 2 diabetes, CKD, and high CV risk. The FDA approved sotagliflozin in 2023 for reducing cardiovascular death and hospitalization in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 1:25 pm

ESPR

Esperion Therapeutics Inc's (NASDAQ:ESPR) stock is trading higher after the FDA approved new label expansions for its drugs NEXLETOL and NEXLIZET, based on CLEAR Outcomes data. These expansions include indications for cardiovascular risk reduction and LDL-C lowering in primary and secondary prevention patients. The approvals make over 70 million patients eligible for these treatments. The company also anticipates a final determination from the European Medicines Agency on label expansions in Europe by the second quarter of 2024.

Portfolio Pulse from Vandana Singh

March 25, 2024 | 1:24 pm

KHC

Kraft Heinz has been selected to receive up to $170 million from the U.S. Department of Energy to implement clean energy projects at 10 of its U.S. plants, aiming to reduce carbon emissions by over 99% from 2022 levels. This funding supports Kraft Heinz's goal of achieving net-zero greenhouse gas emissions by 2050. The projects will involve installing various technologies like heat pumps and solar panels, expected to create 500 construction jobs. This initiative is part of Kraft Heinz's broader ESG goals and its commitment to environmental sustainability.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 1:12 pm